Gladstone NOW: The Campaign Join Us on the Journey ✕
16 - 30 of 1364 Results Clear All
San Francisco Business Times—In this commentary, Gladstone President Deepak Srivastava warns that severe funding cuts from the National Institutes of Health would put lifesaving biomedical research—and patients—at risk.
Gladstone Experts Srivastava Lab
Magnus Hoffmann explains the science behind cancer vaccines and how they could change the game.
Gladstone Experts Cancer Infectious Disease
Jaenisch is recognized for his trailblazing contributions to epigenetics and stem cell biology, which have shaped modern regenerative medicine.
Awards News Release Ogawa Stem Cell Prize Stem Cells/iPSCs
A discovery about the consequence of neuron overactivity could lead to new methods of treating or preventing Parkinson’s disease.
News Release Research (Publication) Parkinson’s Disease Neurological Disease Nakamura Lab
Oscar Yip is advancing Alzheimer’s research in Yadong Huang’s lab at Gladstone while drawing inspiration from his family, community, and his broader goal of helping patients.
Graduate Students and Postdocs Profile Alzheimer’s Disease
Robert and Linda Mahley’s commitment to trainee development continues through Gladstone’s annual Career Advancement Awards.
Graduate Students and Postdocs History
NOMIS–Gladstone Fellow Yuliya Voskobiynyk, PhD, shares her journey from Ukraine to Gladstone and how her research on microglia could shed light on brain function and diseases like epilepsy and Alzheimer’s.
Graduate Students and Postdocs Profile Neurological Disease NOMIS
NOMIS–Gladstone Fellow Myung Jin Yang is uncovering how the brain clears waste without traditional lymphatic vessels, a mystery that could shed light on aging and neurodegenerative diseases.
Graduate Students and Postdocs Profile Neurological Disease NOMIS
The NOMIS-Gladstone Fellowship Program empowers early-career scientists to push the boundaries of neuroscience and unlock the brain’s deepest mysteries.
Institutional News Neurological Disease Mucke Lab NOMIS
The San Francisco Standard—In this opinion piece, Melanie Ott, director of the Gladstone Institute of Virology, writes that halting mRNA research right now is like banning ChatGPT—it's not just scientific negligence, but strategic self-sabotage. She proposes ways for California to take the lead by funding crucial research at the state level.
Gladstone Experts Cancer COVID-19 HIV/AIDS Infectious Disease Ott Lab
ABC7 News—Scientific advances have brought us closer than ever to contemplating cures for many devastating diseases—Parkinson’s, type 1 diabetes, certain cancers, HIV/AIDS. Gladstone President Deepak Srivastava comments on how proposed cuts to the National Institutes of Health budget would slow this progress and the very research that could save millions of lives. He explains why this moment matters and why continued investment in science is critical.
Gladstone Experts Srivastava Lab
Jones lent Gladstone his time and expertise for nearly 50 years.
History Institutional News
ABC7 News—Gladstone alumnus Arye Elfenbein and his business partner, Justin Kolbeck, founded Wildtype to create cell-cultured seafood. Their company uses the same technology—known as induced pluripotent stem cells—that Elfenbein learned while working in the lab of Deepak Srivastava at Gladstone.
Gladstone Experts Srivastava Lab
An in-depth explainer about different types of vaccines and what happens in the body after vaccination.
Gladstone Experts COVID-19 Deep Dive
Chemical & Engineering News—Gladstone Investigator Jennifer Doudna is receiving the highest honor given by the American Chemical Society for discoveries on ribozyme function and CRISPR gene editing, and for her international science leadership.
Awards Gladstone Experts Doudna Lab
